Company: PTPI
Filing Date: 2025-02-19
Form Type: 424B4
Source: 0001410578-25-000164
Chunk: 223

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-19
Form: 424B4
Chunk 223
---
 leases was as follows:

| ​                               | ​ 
 ​ | ​ |                       ​ 
 As of December 31, 2023 | ​ | ​ |                       ​ 
 As of December 31, 2022 |
|:--------------------------------|:--|:--|------------------------:|:--|:--|------------------------:|
| Operating lease ROU asset:      |   | ​ |                         |   | ​ |                         |
| Other assets                    | ​ | $ |                 226,259 | ​ | $ |                 358,472 |
| ​                               | ​ | ​ |                       ​ | ​ | ​ |                       ​ |
| Operating lease liability:      | ​ |   |                         | ​ |   |                         |
| Other current liabilities       | ​ | $ |                 125,022 | ​ | $ |                 142,340 |
| Other long-term liabilities     | ​ |   |                 137,655 | ​ |   |                 262,677 |
| Total operating lease liability | ​ | $ |                 262,677 | ​ | $ |                 405,017 |

Supplemental lease term and discount rate information related to leases was as follows:

| ​                                                         
 ​                                                         | ​ |                       ​ 
 As of December 31, 2023 | ​ |                       ​ 
 As of December 31, 2022 | ​ 
 ​ |
|:----------------------------------------------------------|:--|------------------------:|:--|------------------------:|:--|
| Weighted-average remaining lease terms – operating leases |   |               1.7 years |   |               2.7 years | ​ |
| Weighted-average discount rate – operating leases         |   |                    12.6 | % |                    12.6 | % |

Supplemental cash flow information related to leases was as follows:

| ​                                          | ​ |                   ​ |       ​ | ​ |    ​ |       ​ |
| ​                                          | ​ | For the Years Ended |         |   |      |         |
| ​                                          | ​ |        December 31, |         |   |      |         |
| ​                                          |   |                2023 |         |   | 2022 |         |
| Operating cash flows from operating leases | ​ |                   $ | 189,374 | ​ |    $ | 187,739 |

Future minimum lease payments under non-cancelable leases as of December 31, 2023, were as